Preoperative C-reactive protein-to-albumin ratio for perioperative risk stratification in penetrating crohn’s disease: identification of a candidate rule-out threshold (a propensity score-matched cohort study)
Surgery Today · 2025
DOI: 10.1007/s00595-025-03207-7 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Surgery Today, 2025. Verfasst von Kinuko Nagayoshi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. nag…. Hauptthemen laut MEDLINE: Crohn Disease, C-Reactive Protein, Propensity Score, Serum Albumin. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Determining the optimal timing of surgery for Crohn disease (CD) is challenging. The C-reactive protein-to-albumin ratio (CAR) is inexpensive and widely available; however, its utility in determining surgical timing remains unclear. METHODS: We retrospectively analyzed 112 cases of penetrating-type CD resection (screened 2010-2024). Preoperative CAR was measured within 7 days of surgery. A receiver operating characteristic analysis defined the CAR threshold to maximize the negative predictive value (NPV) for 30-day complications. Patients were categorized as having a low or high CAR and were matched 1:1 using propensity scores. The early morbidity and 5-year re-operation-free survival rates were compared. RESULTS: A CAR cutoff value of 0.102 yielded the highest NPV. A high CAR was associated with increased overall morbidity (55% vs. 20%) and increased wound infection (21% vs. 5%). After matching (25 pairs), a high CAR was correlated with more complications (52% vs. 24%; P = 0.04) and prolonged stay (median 17 vs. 11 days; P = 0.02). The five-year reoperation risk was higher with a high CAR (14.6% vs. 4.0%; P = 0.03). CONCLUSIONS: Preoperative CAR < 0.102 indicates a candidate rule-out threshold for elective CD surgery, predicting fewer early complications and a lower 5-year re-operation rate. Because CAR is rapidly available and treatment-agnostic, serial monitoring could support a testable preoperative timing framework. Further prospective validation is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. nagayoshi.kinuko.232@m.kyushu-u.ac.jp.
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Zitieren
APA
Nagayoshi, K., Mizuuchi, Y., Fujimoto, T., Tamura, K., Nakata, K., Ohuchida, K., & Nakamura, M. (2025). Preoperative C-reactive protein-to-albumin ratio for perioperative risk stratification in penetrating crohn’s disease: identification of a candidate rule-out threshold (a propensity score-matched cohort study). Surgery Today. https://doi.org/10.1007/s00595-025-03207-7
Vancouver
Nagayoshi K, Mizuuchi Y, Fujimoto T, Tamura K, Nakata K, Ohuchida K, et al. Preoperative C-reactive protein-to-albumin ratio for perioperative risk stratification in penetrating crohn’s disease: identification of a candidate rule-out threshold (a propensity score-matched cohort study). Surgery Today. 2025. doi:10.1007/s00595-025-03207-7
BibTeX
@article{Nagayoshi2025,
author = {Nagayoshi, Kinuko and Mizuuchi, Yusuke and Fujimoto, Takaaki and Tamura, Koji and Nakata, Kohei and Ohuchida, Kenoki and Nakamura, Masafumi},
title = {Preoperative C-reactive protein-to-albumin ratio for perioperative risk stratification in penetrating crohn’s disease: identification of a candidate rule-out threshold (a propensity score-matched cohort study)},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-025-03207-7}
}
EUVIMED